The Research Behind the Results
BiomiXin holds Taiwan and US patents, co-publishes with NPUST, and validates every product in controlled field trials before commercial distribution.
How we develop and validate our products
Strain Isolation
In-house R&D centre isolates and characterises novel probiotic strains and bioactive compounds.
Lab Validation
NPUST partnership validates mechanisms and efficacy in controlled laboratory settings.
Field Trials
Farm-level controlled trials in target species and markets. Data collected and analysed.
Commercial Release
Only after trial success is the product made available for commercial distribution.
Peer-reviewed research
Bacillus amyloliquefaciens supplementation improves growth performance and immune response in weaned pigs
Demonstrates significant improvements in ADG, FCR, and immune marker expression in nursery pigs supplemented with BiomiXin's proprietary Bacillus strain.
Vibrio harveyi prevention in Litopenaeus vannamei using algae-derived polysaccharide supplementation
Field and laboratory validation of AlgiShield's efficacy in reducing Vibrio harveyi colonisation and improving survival rates in commercial shrimp production.
Full papers available on request for qualified distributors and nutritionists.
From the farm, not just the lab
35-day trial, 10,000-bird flock, Central Luzon. Full report available on request.
42-day post-weaning trial. Reduced diarrhea incidence and improved feed intake.
90-day grow-out trial under Vibrio challenge conditions. Significant reduction in EMS incidence.
Intellectual property
Taiwan Patent
Proprietary Bacillus amyloliquefaciens probiotic strain for livestock health applications. Co-developed with NPUST.
US Patent
Clostridium butyricum strain and herbal extract formulation targeting PRRS control in swine. Filed and granted.
Taiwan Patent (AlgiShield)
Ulva spp. extraction and standardisation process for producing consistent sulfated polysaccharide concentrations for feed applications.